4.6

CiteScore

2.2

Impact Factor
  • ISSN 1674-8301
  • CN 32-1810/R
Akihiko Nogami. Trigger elimination of polymorphic ventricular tachycardia and ventricular fibrillation by catheter ablation: trigger and substrate modification[J]. The Journal of Biomedical Research, 2015, 29(1): 44-51. DOI: 10.7555/JBR.29.20140156
Citation: Akihiko Nogami. Trigger elimination of polymorphic ventricular tachycardia and ventricular fibrillation by catheter ablation: trigger and substrate modification[J]. The Journal of Biomedical Research, 2015, 29(1): 44-51. DOI: 10.7555/JBR.29.20140156

Trigger elimination of polymorphic ventricular tachycardia and ventricular fibrillation by catheter ablation: trigger and substrate modification

More Information
  • Received Date: November 19, 2014
  • Ventricular fibrillation (VF) is a malignant arrhythmia, usually initiated by a ventricular premature contraction (VPC) during the vulnerable period of cardiac repolarization. Ablation therapy for VF has been described and increasingly reported. Targets for VF triggers are VPCs preceded by Purkinje potentials or from the right ventricular outflow tract (RVOT) in structurally normal hearts, and VPC triggers preceded by Purkinje potentials in ischemic cardiomyopathy. During the session, mapping should be focused on the earliest activation and determining the earliest potential is the key to a successful ablation. However, suppression of VF can be achieved by not only the elimination of triggering VPCs, but also by substrate modification of possible reentry circuits in the Purkinje network, or between the PA and RVOT. The most important issue before the ablation session is the recording of the 12-lead ECG of the triggering event, which can prove invaluable in regionalizing the origin of the triggering VPC for more detailed mapping. In cases where the VPC is not spontaneous or inducible, ablation may be performed by pace mapping. Further studies are needed to evaluate the precise mechanisms of this arrhythmia.
  • Related Articles

    [1]Izzatullo Ziyoyiddin o`g`li Abdullaev, Ulugbek Gapparjanovich Gayibov, Sirojiddin Zoirovich Omonturdiev, Sobirova Fotima Azamjonovna, Sabina Narimanovna Gayibova, Takhir Fatikhovich Aripov. Molecular pathways in cardiovascular disease under hypoxia: Mechanisms, biomarkers, and therapeutic targets[J]. The Journal of Biomedical Research. DOI: 10.7555/JBR.38.20240387
    [2]Jing Xue, Linwei Zhang, Jingxian Tao, Xuexue Xie, Xi Wang, Linlin Wu, Shuhu Du, Ninghua Tan, Yang Jin, Jianming Ju, Junting Fan, Jun Wang, Fei Huan, Rong Gao. A novel bellidifolin intervention mitigates nonalcoholic fatty liver disease-like changes induced by bisphenol F[J]. The Journal of Biomedical Research, 2024, 38(5): 451-463. DOI: 10.7555/JBR.37.20230169
    [3]Zhang Jingdong, Fox Howard, Xiong Huangui. Severer nodular lesion in white matter than in gray matter in simian immunodeficiency virus-infected monkey, but not closely correlated with viral infection[J]. The Journal of Biomedical Research, 2020, 34(4): 292-300. DOI: 10.7555/JBR.33.20180047
    [4]Du Haina, Song Guoxin, Fang Mingzhi, Shu Yongqian, Zhao Xin, Zhu Lingjun. A meta-analysis of caspase-8 -652 6N del polymorphism and digestive tract cancer risk[J]. The Journal of Biomedical Research, 2019, 33(3): 173-180. DOI: 10.7555/JBR.32.20160030
    [5]Xinglong Yang, Jingdong Zhang, Lian Duan, Huangui Xiong, Yanping Jiang, Houcheng Liang. Microglia activation mediated by toll-like receptor-4 impairs brain white matter tracts in rats[J]. The Journal of Biomedical Research, 2018, 32(2): 136-144. DOI: 10.7555/JBR.32.20170033
    [6]Ji-Youn Kim, Ho-Gyu Choi, Hae-Miru Lee, Geum-A Lee, Kyung-A Hwang, Kyung-Chul Choi. Effects of bisphenol compounds on the growth and epithelial mesenchymal transition of MCF-7 CV human breast cancer cells[J]. The Journal of Biomedical Research, 2017, 31(4): 358-369. DOI: 10.7555/JBR.31.20160162
    [7]Qian Liu, Cheng Xu, Guixiang Ji, Hui Liu, Wentao Shao, Chunlan Zhang, Aihua Gu, Peng Zhao. Effect of exposure to ambient PM2.5 pollution on the risk of respiratory tract diseases: a meta-analysis of cohort studies[J]. The Journal of Biomedical Research, 2017, 31(2): 130-142. DOI: 10.7555/JBR.31.20160071
    [8]Alexander E. Berezin, Alexander A. Kremzer, Tatayna A. Samura. Circulating thrombospondin-2 in patients with moderate-to-severe chronic heart failure due to coronary artery disease[J]. The Journal of Biomedical Research, 2016, 30(1): 32-39. DOI: 10.7555/JBR.30.20140025
    [9]Yang Zhou, Ouyang Ling, Li Bo. Expression and significance of lysyl oxidase-like 1 and fibulin-5 in the cardinal ligament tissue of patients with pelvic floor dysfunction[J]. The Journal of Biomedical Research, 2013, 27(1): 23-28. DOI: 10.7555/JBR.27.20110142
    [10]Jing Cai, Yanhui Sheng, Shijiang Zhang, Wei Sun, Rong Yang, Liping Miao, Xiangqing Kong. Preliminary feasibility and hemodynamic performance of a newly-developed self-expanding bioprosthesis and 16-F delivery system in transcatheter aortic valve implantation in sheep[J]. The Journal of Biomedical Research, 2012, 26(3): 211-218. DOI: 10.7555/JBR.26.20120011
  • Cited by

    Periodical cited type(2)

    1. Lombard L, Sandoval-Denis M, Lamprecht SC, et al. Epitypification of Fusarium oxysporum - clearing the taxonomic chaos. Persoonia, 2019, 43: 1-47. DOI:10.3767/persoonia.2019.43.01
    2. Urbaniak C, van Dam P, Zaborin A, et al. Genomic Characterization and Virulence Potential of Two Fusarium oxysporum Isolates Cultured from the International Space Station. mSystems, 2019, 4(2): e00345-18. DOI:10.1128/mSystems.00345-18

    Other cited types(0)

Catalog

    Article Metrics

    Article views (3565) PDF downloads (542) Cited by(2)
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return